Article Detail - JE Part B
Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer (A58679) - R4 - Effective October 1, 2023
This coverage article has been revised and published for notice under contract numbers: 01112 (NCA), 01182 (SCA), 01212 (HI and Territories), and 01312 (NV).
Effective Date: October 1, 2023
Summary of Article Changes: Under ICD-10 Codes that Support Medical Necessity Group 1: Codes the description was revised for Q85.81 and added D13.91. This revision is due to the Annual ICD-10-CM Update and will become effective on 10/1/2023.
Under CMS National Coverage Policy updated section heading. Under Article Text revised the 3rd and 6th bullets to remove "DEX Z-Code™" and replaced with "DEX Z-Code®". This revision is effective on 10/1/2023.
Visit the Noridian Medicare Coverage Articles webpage to view the complete listing of coverage articles and/or access the Active, Future, or Retired articles available in the CMS MCD.
